Autosomal Dominant Pedigree Charts: Rules, Math, Penetrance, and Expressivity
Master autosomal dominant pedigree analysis with our guide on vertical transmission, 50% risk math, incomplete penetrance traps, variable expressivity, de novo mutations, and USMLE/MCAT quizzes.
Key Takeaways
- Vertical Generational Pattern: Autosomal dominant traits appear in every consecutive generation without skipping, with affected individuals having at least one affected parent.
- 50% Inheritance Risk: An affected heterozygous parent (Aa) paired with an unaffected partner (aa) has a 50% probability (1/2) of passing the condition to each child, regardless of sex.
- Incomplete Penetrance Trap: Incomplete penetrance allows a dominant allele to pass through an unaffected parent, creating a false impression of a skipped generation on a pedigree chart.
- Homozygous Lethality Ratio: In disorders like Achondroplasia (FGFR3 c.1138G>A, p.Gly380Arg), homozygous dominant (AA) fetuses are non-viable. Consequently, the probability of an affected child surviving to birth from two affected parents (Aa × Aa) is 2/3 (66.7%).
- Complete Pedigree Series: This article forms part of Biogistry's clinical genetics educational library covering all major inheritance patterns.
Introduction to Autosomal Dominant Pedigree Charts
Autosomal dominant (AD) inheritance is a primary transmission model for hundreds of genetic disorders, including Huntington Disease (HTT), Marfan Syndrome (FBN1), Neurofibromatosis Type 1 (NF1), Achondroplasia (FGFR3), and Familial Hypercholesterolemia (LDLR).
In clinical genetics and board examinations, identifying an autosomal dominant pedigree chart appears straightforward due to vertical transmission across generations. However, examiners frequently introduce complex clinical nuances, such as incomplete penetrance, variable expressivity, age of onset, homozygous lethality, and germline mosaicism.
This guide provides a comprehensive analysis of autosomal dominant pedigrees. You will learn the hallmark recognition criteria, mathematical risk calculations, penetrance equations, advanced edge cases, and how to automate risk modeling using Biogistry. For a broad comparison across all inheritance modes, consult our Master Pedigree Chart Inheritance Patterns Guide.
Visualizing Autosomal Dominant Inheritance
The vector diagram below illustrates a classic three-generation autosomal dominant pedigree featuring vertical transmission and father-to-son (male-to-male) link confirmation:
Figure 1: Classic three-generation Autosomal Dominant pedigree displaying vertical transmission and father-to-son transmission (I-1 to II-1, and II-1 to III-1) confirming an autosomal gene locus.
Quick Reference: Autosomal Dominant Inheritance Summary
| Clinical Parameter | Standard Value / Characteristic |
|---|---|
| Generational Transmission | Vertical (Appears in every consecutive generation without skipping). |
| Sex Distribution Ratio | 1:1 Male to Female ratio (Autosomal gene location). |
| Parental Phenotype | Affected individuals must have at least one affected parent (unless de novo mutation or incomplete penetrance occurs). |
| Recurrence Risk per Pregnancy | 50% (1/2) for heterozygous affected parent paired with unaffected partner (Aa × aa). |
| Male-to-Male Transmission | Present (Father-to-son transmission confirms autosomal location and rules out X-linked traits). |
| Unaffected Offspring Genotype | Unaffected individuals are homozygous recessive (aa) and cannot transmit the allele (unless non-penetrant). |
| Homozygous Dominant Effect | Often causes embryonic or neonatal lethality (e.g., Achondroplasia FGFR3 c.1138G>A). |
| Classic Disease Examples | Huntington Disease (HTT), Marfan Syndrome (FBN1), Neurofibromatosis Type 1 (NF1), Achondroplasia (FGFR3). |
Hallmark Rules of Autosomal Dominant Inheritance
To confirm an autosomal dominant pattern on a pedigree chart, systematically verify these four core criteria:
1. Vertical Transmission Across Generations
The defining visual characteristic of an autosomal dominant pedigree is vertical transmission. The condition moves directly down family branches from parent to child, appearing in Generation I, Generation II, Generation III, and beyond without skipping generations.
2. Equal Gender Frequency
Because the gene resides on an autosome (chromosomes 1 through 22), males and females inherit the mutated allele with equal frequency. A large autosomal dominant pedigree will display roughly equal numbers of affected males and affected females. Contrast this with X-linked dominant traits which display a female-biased ratio.
3. Male-to-Male (Father-to-Son) Transmission
Father-to-son transmission is a critical diagnostic marker. Fathers pass their Y chromosome to sons and their X chromosome to daughters. Observing an affected father passing the condition to his son confirms that the disease gene is autosomal, definitively ruling out X-linked dominant and X-linked recessive inheritance.
4. 50% Transmission Probability per Pregnancy
Because affected individuals are almost always heterozygous (Aa) for rare dominant traits, pairing an affected parent (Aa) with an unaffected partner (aa) results in a 50% (1/2) probability of passing the disease allele to each offspring.
Genotype Deduction Rules in Dominant Pedigrees
When annotating genotypes on an autosomal dominant pedigree chart, apply these three rules:
| Rule | Mandate & Clinical Criteria |
|---|---|
| Rule 1: Unaffected Individuals | All phenotypically normal individuals must be homozygous recessive (aa), assuming complete penetrance. Unaffected individuals cannot pass the trait. |
| Rule 2: Affected Individuals with Unaffected Parent | Any affected individual who has one unaffected parent (aa) MUST be heterozygous (Aa). |
| Rule 3: Homozygous Dominant Genotypes (AA) | Homozygous dominant individuals (AA) are extremely rare and typically result from two affected heterozygous parents (Aa × Aa). In many conditions, AA is lethal. |
Mathematical Probability Rules in Autosomal Dominant Pedigrees
1. Standard Heterozygous Transmission Risk (50%)
When an affected heterozygous individual (Aa) pairs with an unaffected partner (aa), the Punnett square produces:
P(Aa) = 1/2 (50% Heterozygous Affected)
P(aa) = 1/2 (50% Homozygous Unaffected)
Every child born to an affected heterozygous parent has an independent 50% chance of inheriting the disease allele.
2. Homozygous Dominant Lethality Math (Achondroplasia 2/3 Rule)
A classic trap on medical genetics examinations involves disorders where the homozygous dominant genotype (AA) is embryonic or neonatally lethal.
Clinical Case Example:
Achondroplasia is an autosomal dominant form of short-limbed dwarfism caused by a gain-of-function point mutation in the FGFR3 gene (c.1138G>A, p.Gly380Arg). Heterozygous individuals (Aa) display dwarfism. Homozygous dominant individuals (AA) suffer severe thoracic cage dysplasia resulting in deadbirth or early neonatal death.
The Problem:
If two individuals with Achondroplasia (Aa × Aa) conceive, what is the probability that their live-born child will also have Achondroplasia?
Step-by-Step Solution:
- Parents' Genotypes: Both parents are heterozygous affected (Aa × Aa).
- Punnett Square Results at Fertilization: Ratio: 1 AA (Lethal) : 2 Aa (Affected Dwarfism) : 1 aa (Unaffected Average Height)
- Eliminate Non-Viable Genotypes: The AA genotype results in embryonic or neonatal death and is excluded from the surviving live-born offspring pool.
- Calculate Surviving Live-Born Ratio: Surviving Outcomes: 2 Aa and 1 aa (Total of 3 viable outcomes)
- Final Probability: Out of 3 live-born children, 2 will have Achondroplasia (Aa).
P(Achondroplasia | Live Birth) = 2/3 (66.7%)
P(Average Height | Live Birth) = 1/3 (33.3%)
Advanced Edge Cases: Penetrance, Expressivity, and Mosaicism
Standard Mendelian models assume that carrying a dominant allele guarantees disease expression. Medical board examinations test five specific edge cases where this assumption breaks down.
1. Incomplete Penetrance
Penetrance is defined as the proportion of individuals carrying a specific gene mutation who actually express the clinical phenotype.
Penetrance = Number of Individuals Showing Clinical Symptoms/Total Number of Individuals Carrying Mutation Allele
- Complete Penetrance (100%): Every individual with the Aa genotype shows symptoms (e.g., Achondroplasia).
- Incomplete Penetrance (<100%): Some individuals carry the Aa genotype but show zero clinical symptoms.
The Pedigree Skipping Trap:
Incomplete penetrance allows a dominant disorder to appear to skip a generation. An unaffected individual (Aa) acts as a non-penetrant carrier, receiving the allele from an affected parent and transmitting it to an affected child.
| Generation | Individual | Genotype & Transmission Role |
|---|---|---|
| Generation I | Affected Grandfather | Aa (Transmits disease allele to daughter) |
| Generation II | Unaffected Mother | Aa (Non-Penetrant Obligate Carrier - Skipped Generation) |
| Generation III | Affected Son | Aa (Inherits disease allele from mother and expresses trait) |
Penetrance Risk Formula:
If a condition has a penetrance rate P (expressed as a decimal, such as 0.80 for 80% penetrance), the probability that a child born to an affected parent (Aa) will express clinical symptoms is:
P(Affected Child) = P(Inheriting Allele) × Penetrance Rate = 0.50 × P
If penetrance is 80% (P = 0.80), the child's overall risk of being clinically affected is 0.50 × 0.80 = 0.40 (40%).
2. Age-Dependent Penetrance (Delayed Age of Onset)
Certain autosomal dominant disorders do not manifest clinically at birth. Instead, symptoms develop later in adult life as somatic damage accumulates.
Huntington Disease Example:
Huntington Disease is caused by a CAG trinucleotide repeat expansion in the HTT gene (>36 CAG repeats). Individuals carrying the expanded allele are born clinically asymptomatic. Symptoms typically emerge between ages 30 and 50.
- At birth: Clinical penetrance is 0%.
- At age 30: Clinical penetrance is approximately 25%.
- At age 50: Clinical penetrance approaches 95%.
- At age 70: Clinical penetrance reaches 100%.
Exam Rule: When evaluating a pedigree for adult-onset disorders, an unaffected 20-year-old child of an affected parent still has a 50% genetic risk of carrying the allele, even if they currently show zero symptoms.
3. Variable Expressivity
Do not confuse incomplete penetrance with variable expressivity.
- Incomplete Penetrance: An all-or-none phenomenon (individual either shows symptoms or shows zero symptoms).
- Variable Expressivity: All individuals carrying the mutation express clinical symptoms, but the severity and symptom combination vary dramatically between family members.
Neurofibromatosis Type 1 (NF1) Example:
NF1 (NF1 gene mutation) exhibits 100% penetrance with extremely variable expressivity. Within the exact same family sharing identical mutations:
- Parent: Presents with mild cutaneous café-au-lait spots and Lisch nodules in the iris.
- Child: Presents with severe plexiform neurofibromas, optic pathway gliomas, and scoliosis.
4. De Novo (New) Mutations
A de novo mutation occurs when a spontaneous gene mutation arises in a single egg or sperm cell during gametogenesis in healthy, non-carrier parents.
Pedigree Appearance:
A child is born with an autosomal dominant condition (such as Achondroplasia or Marfan Syndrome), but both biological parents are confirmed non-carriers (aa) with zero family history.
Recurrence Risk:
Because the mutation was an isolated event in a single gamete, the recurrence risk for future siblings born to the same parents drops back to the general population baseline (<1%). However, the affected individual (Aa) will have a 50% risk of passing the condition to their own future offspring.
5. Germline (Gonadal) Mosaicism
Germline mosaicism occurs when a post-zygotic mutation arises during early embryonic development in the progenitor cells that give rise to the gonads (sperm or egg cells).
Pedigree Appearance:
Phenotypically healthy parents with negative blood genetic tests give birth to multiple children affected by an autosomal dominant condition.
Mechanism:
The parent's somatic tissues (blood, skin) are wild-type (aa), but a significant subpopulation of their germ cells (sperm or eggs) carries the dominant mutation (Aa).
Exam Trap: If a single affected child is born to healthy parents, suspect a de novo mutation. If two or more siblings inherit the exact same dominant condition from healthy parents, suspect germline mosaicism.
Biogistry Dual Showcase: Free Pedigree Maker and Paid Dominant Risk Engine
Biogistry provides tools for both basic pedigree layout and automated dominant risk calculations.
Part 1: Draw Autosomal Dominant Trees with Biogistry Free Maker
Building an autosomal dominant pedigree using Biogistry's free browser canvas requires simple steps:
- Create Family Nodes: Place parents and children across multiple generations on the canvas.
- Assign Dominant Affection Status: Click affected individuals across consecutive generations and set them to Affected.
- Annotate Non-Penetrant Individuals: If a generation is skipped, select the unaffected intermediate node, open clinical properties, and tag Non-Penetrant Carrier.
- Export Diagram Files: Download clean vector files (SVG or PNG) for clinical documentation or study guides. Try our Free Pedigree Chart Maker online.
Part 2: Automate Dominant Detection with Biogistry Paid Engine
For complex pedigrees involving variable expressivity or non-penetrance, Biogistry's paid engine automates dominant likelihood scoring directly inside your browser.
- Automated Dominant Detection: Evaluates vertical transmission depth, father-to-son (male-to-male) links, and affected parent patterns to calculate pattern confidence.
- Non-Penetrance Penalty Scaling: When an affected child has unaffected parents, Biogistry applies a soft penalty scaling factor while flagging potential non-penetrance or de novo events.
- Germline Mosaicism Boost: If affected half-siblings share an unaffected parent, Biogistry boosts autosomal dominant confidence, identifying parental germline mosaicism and calculating recurrence risk.
High-Yield Clinical Vignette Quizzes
Test your understanding of autosomal dominant inheritance with these board-style practice questions.
Question 1: Achondroplasia Live-Birth Probability
Clinical Stem: A 29-year-old male and a 27-year-old female, both clinically diagnosed with Achondroplasia (Aa), consult a genetic counselor for prenatal planning. Achondroplasia is an autosomal dominant disorder caused by a gain-of-function mutation in the FGFR3 gene (c.1138G>A). The couple is informed that homozygous dominant genotypes (AA) are non-viable and result in early neonatal death.
Question: If the couple conceives, what is the probability that they will give birth to a live-born infant with average height (aa)?
- A) 0%
- B) 25% (1/4)
- C) 33.3% (1/3)
- D) 50% (1/2)
Click to View Correct Answer and Explanation
Correct Answer: C) 33.3% (1/3)
Detailed Logic Step-by-Step:
- Both parents are heterozygous for Achondroplasia (Aa × Aa).
- Punnett square cross yields at conception: Genotypes: 1 AA : 2 Aa : 1 aa
- Homozygous dominant (AA) fetuses suffer severe thoracic dysplasia and are non-viable (lethal). This eliminates AA from live births.
- The remaining viable live-born possibilities are 2 Aa (Achondroplasia) and 1 aa (Average height), totaling 3 viable outcomes.
- The probability of a live-born infant having average height (aa) is: P(aa | Live Birth) = 1/3 ≈ 33.3%
Question 2: Incomplete Penetrance Risk Calculation
Clinical Stem: A 25-year-old male presents for counseling. His mother carries a confirmed autosomal dominant mutation for hereditary retinoblastoma (RB1 gene). Retinoblastoma exhibits an 80% penetrance rate (P = 0.80). The patient's mother is clinically healthy and has normal eye examinations. The patient's maternal grandfather had bilateral retinoblastoma during childhood. The patient is currently asymptomatic.
Question: What is the probability that the 25-year-old patient carries the disease-causing mutation?
- A) 50%
- B) 40%
- C) 25%
- D) 20%
Click to View Correct Answer and Explanation
Correct Answer: A) 50%
Detailed Logic Step-by-Step:
- The clinical stem states that the mother carries the confirmed mutation (Aa), even though she is non-penetrant (healthy).
- Because the mother is a confirmed carrier (Aa), the probability that she transmits the mutation allele to her son is 50% (1/2), regardless of her own penetrance.
- The question specifically asks for the probability that the patient carries the mutation (not whether he expresses symptoms).
- Therefore, the probability of inheriting the allele is simply 50% × Mother's Carrier Status (100%) = 50%.
- Note on Disease Expression: If the question asked for his risk of developing retinoblastoma, it would be 50% × 80% = 40%.
Conclusion and Deep-Dive Pedigree Series
Mastering autosomal dominant pedigree charts requires identifying vertical transmission, applying 50% inheritance math, recognizing homozygous lethality ratios, and adjusting for clinical nuances like incomplete penetrance, variable expressivity, and age of onset.
Explore the rest of our dedicated pedigree inheritance guides:
- The Master Guide to Pedigree Chart Inheritance Patterns
- Autosomal Recessive Pedigree Chart Guide
- X-Linked Recessive Pedigree Chart Guide
- X-Linked Dominant Pedigree Chart Guide
- Y-Linked (Holandric) Pedigree Chart Guide
- Mitochondrial (Maternal) Pedigree Chart Guide
Ready to build or analyze your own autosomal dominant pedigree charts? Use Biogistry's free tools to sketch family trees or explore automated risk analysis for complex clinical cases.